$1.08 Billion is the total value of Soleus Capital Management, L.P.'s 91 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 59.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XBI | New | SPDR SER TRcall | $91,275,000 | – | 1,250,000 | +100.0% | 8.42% | – |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $64,861,959 | +21.0% | 287,165 | +18.3% | 5.98% | +0.5% |
TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $61,732,073 | +92.9% | 6,052,164 | +42.4% | 5.70% | +60.1% |
EDAP | Buy | EDAP TMS S Asponsored adr | $43,922,624 | -13.0% | 6,256,784 | +14.3% | 4.05% | -27.8% |
SRDX | Sell | SURMODICS INC | $39,498,362 | -5.6% | 1,230,862 | -7.9% | 3.64% | -21.7% |
ORGO | Buy | ORGANOGENESIS HLDGS INC | $39,101,798 | +0.4% | 12,296,163 | +4.8% | 3.61% | -16.7% |
New | GSK PLCsponsored adr | $34,183,750 | – | 943,000 | +100.0% | 3.15% | – | |
HUM | Buy | HUMANA INC | $33,473,549 | +19.3% | 68,802 | +9.6% | 3.09% | -1.0% |
IRMD | Sell | IRADIMED CORP | $27,873,500 | -24.5% | 628,206 | -18.8% | 2.57% | -37.4% |
PCVX | Sell | VAXCYTE INC | $25,472,157 | -10.7% | 499,650 | -12.5% | 2.35% | -25.9% |
TMCI | New | TREACE MED CONCEPTS INC | $25,011,560 | – | 1,907,823 | +100.0% | 2.31% | – |
TGTX | Buy | TG THERAPEUTICS INC | $24,113,434 | +122.9% | 2,884,382 | +562.3% | 2.22% | +85.0% |
NPCE | Sell | NEUROPACE INC | $23,996,175 | +116.7% | 2,466,205 | -0.0% | 2.21% | +79.9% |
Sell | ARCELLX INC | $23,098,719 | -27.1% | 643,777 | -35.8% | 2.13% | -39.5% | |
Buy | TANGO THERAPEUTICS INC | $21,720,754 | +268.2% | 1,929,019 | +8.6% | 2.00% | +205.5% | |
PODD | New | INSULET CORP | $20,363,683 | – | 127,680 | +100.0% | 1.88% | – |
EOLS | Buy | EVOLUS INC | $18,992,920 | +156.9% | 2,078,000 | +104.3% | 1.75% | +113.1% |
AXGN | Buy | AXOGEN INC | $18,929,145 | +15.8% | 3,785,829 | +111.5% | 1.75% | -3.9% |
CRL | Sell | CHARLES RIV LABS INTL INC | $18,826,623 | -57.3% | 96,064 | -54.1% | 1.74% | -64.5% |
CELC | Buy | CELCUITY INC | $18,796,264 | -11.0% | 2,056,484 | +6.9% | 1.73% | -26.1% |
SKIN | Buy | THE BEAUTY HEALTH COMPANY | $16,896,454 | -18.7% | 2,806,720 | +13.1% | 1.56% | -32.5% |
AXSM | Buy | AXSOME THERAPEUTICS INC | $16,598,875 | +827.7% | 237,500 | +853.8% | 1.53% | +669.3% |
SNN | Buy | SMITH & NEPHEW PLCspdn adr new | $16,197,103 | +2.7% | 653,900 | +33.6% | 1.49% | -14.8% |
RIGL | Buy | RIGEL PHARMACEUTICALS INC | $15,987,256 | -12.6% | 14,803,015 | +4.4% | 1.48% | -27.4% |
IMVT | Buy | IMMUNOVANT INC | $15,340,606 | +365.8% | 399,599 | +130.2% | 1.42% | +286.6% |
KRYS | Buy | KRYSTAL BIOTECH INC | $13,675,472 | +5.7% | 117,892 | +7.0% | 1.26% | -12.2% |
SIBN | Buy | SI-BONE INC | $13,642,218 | -19.2% | 642,289 | +2.6% | 1.26% | -33.0% |
CVS | Sell | CVS HEALTH CORP | $13,444,120 | -45.2% | 192,554 | -45.8% | 1.24% | -54.6% |
ATRC | New | ATRICURE INC | $13,402,800 | – | 306,000 | +100.0% | 1.24% | – |
EPIX | Buy | ESSA PHARMA INC | $13,247,120 | +16.8% | 4,287,094 | +2.0% | 1.22% | -3.1% |
MREO | New | MEREO BIOPHARMA GROUP PLCspon ads | $12,483,871 | – | 9,677,419 | +100.0% | 1.15% | – |
BHC | Buy | BAUSCH HEALTH COS INC | $11,580,344 | +25.3% | 1,408,801 | +21.9% | 1.07% | +3.9% |
Buy | VERASTEM INC | $10,954,110 | +182.9% | 1,347,369 | +158.9% | 1.01% | +135.1% | |
BNTX | New | BIONTECH SEsponsored ads | $10,646,720 | – | 98,000 | +100.0% | 0.98% | – |
INBX | Buy | INHIBRX INC | $10,077,508 | -18.0% | 549,183 | +16.1% | 0.93% | -31.9% |
New | RAYZEBIO INC | $10,015,819 | – | 451,163 | +100.0% | 0.92% | – | |
New | SOLENO THERAPEUTICS INC | $9,590,750 | – | 325,000 | +100.0% | 0.88% | – | |
MRUS | New | MERUS N V | $9,066,274 | – | 384,490 | +100.0% | 0.84% | – |
BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $7,871,262 | -25.1% | 391,800 | -4.9% | 0.73% | -37.8% |
BCAB | Buy | BIOATLA INC | $7,405,535 | -42.9% | 4,356,197 | +0.8% | 0.68% | -52.6% |
PHVS | Sell | PHARVARIS N V | $7,178,758 | +21.0% | 343,975 | -12.2% | 0.66% | +0.3% |
CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $7,137,670 | – | 964,550 | +100.0% | 0.66% | – |
Sell | NUVALENT INC | $7,098,504 | -21.0% | 154,416 | -27.5% | 0.66% | -34.4% | |
INSP | Buy | INSPIRE MED SYS INC | $7,064,464 | +224.8% | 35,600 | +431.3% | 0.65% | +169.4% |
EXAS | Buy | EXACT SCIENCES CORP | $6,971,811 | +6.8% | 102,196 | +47.0% | 0.64% | -11.3% |
NRIX | New | NURIX THERAPEUTICS INC | $6,398,040 | – | 814,000 | +100.0% | 0.59% | – |
BLFS | New | BIOLIFE SOLUTIONS INC | $6,062,590 | – | 439,000 | +100.0% | 0.56% | – |
Buy | JASPER THERAPEUTICS INC | $5,810,686 | -45.5% | 8,300,980 | +6.8% | 0.54% | -54.7% | |
IOVA | IOVANCE BIOTHERAPEUTICS INC | $5,640,985 | -35.4% | 1,239,777 | 0.0% | 0.52% | -46.4% | |
NVCR | Buy | NOVOCURE LTD | $5,557,215 | -45.4% | 344,100 | +40.4% | 0.51% | -54.6% |
INSM | New | INSMED INC | $5,504,500 | – | 218,000 | +100.0% | 0.51% | – |
ETNB | Buy | 89BIO INC | $5,342,750 | +24.5% | 346,033 | +52.8% | 0.49% | +3.4% |
URGN | New | UROGEN PHARMA LTD | $5,211,720 | – | 372,000 | +100.0% | 0.48% | – |
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $5,098,027 | +222.5% | 244,627 | +270.6% | 0.47% | +167.0% |
New | THERATECHNOLOGIES INC | $5,012,458 | – | 2,331,376 | +100.0% | 0.46% | – | |
CCCC | C4 THERAPEUTICS INC | $5,007,157 | -32.4% | 2,692,020 | 0.0% | 0.46% | -43.9% | |
CSTL | New | CASTLE BIOSCIENCES INC | $4,788,315 | – | 283,500 | +100.0% | 0.44% | – |
NSPR | INSPIREMD INC | $4,506,479 | +30.3% | 1,378,128 | 0.0% | 0.42% | +8.1% | |
TARS | New | TARSUS PHARMACEUTICALS INC | $4,442,500 | – | 250,000 | +100.0% | 0.41% | – |
MCRB | Sell | SERES THERAPEUTICS INC | $4,333,940 | -55.8% | 1,820,983 | -11.0% | 0.40% | -63.3% |
MIRM | Sell | MIRUM PHARMACEUTICALS INC | $3,254,800 | -28.5% | 103,000 | -41.5% | 0.30% | -40.7% |
APLT | New | APPLIED THERAPEUTICS INC | $2,969,639 | – | 1,192,626 | +100.0% | 0.27% | – |
New | BIOHAVEN LTD | $2,959,938 | – | 113,800 | +100.0% | 0.27% | – | |
Buy | GENEDX HOLDINGS CORP | $2,844,281 | -32.9% | 781,396 | +9.8% | 0.26% | -44.4% | |
KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $2,733,152 | -62.6% | 157,349 | -69.7% | 0.25% | -69.0% |
NTRA | Sell | NATERA INC | $2,715,932 | -66.9% | 61,377 | -63.6% | 0.25% | -72.5% |
DSGN | New | DESIGN THERAPEUTICS INC | $2,419,000 | – | 1,025,000 | +100.0% | 0.22% | – |
LYRA | LYRA THERAPEUTICS INC | $2,316,350 | -4.9% | 592,417 | 0.0% | 0.21% | -21.0% | |
PRAX | Sell | PRAXIS PRECISION MEDICINES I | $1,966,500 | -18.6% | 1,150,000 | -45.2% | 0.18% | -32.5% |
XENE | Sell | XENON PHARMACEUTICALS INC | $1,776,320 | -30.1% | 52,000 | -21.2% | 0.16% | -41.8% |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $1,735,140 | -61.0% | 119,500 | -43.8% | 0.16% | -67.7% |
AADI BIOSCIENCE INC | $1,612,819 | -29.2% | 333,227 | 0.0% | 0.15% | -41.1% | ||
FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $1,575,312 | -60.2% | 123,748 | -43.5% | 0.14% | -67.0% |
ALKS | Sell | ALKERMES PLC | $1,523,744 | -75.0% | 54,400 | -72.0% | 0.14% | -79.1% |
VKTX | Sell | VIKING THERAPEUTICS INC | $1,352,754 | -75.2% | 122,200 | -63.7% | 0.12% | -79.4% |
ANNX | Sell | ANNEXON INC | $1,216,344 | -44.3% | 515,400 | -16.9% | 0.11% | -53.9% |
LQDA | LIQUIDIA CORPORATION | $1,109,500 | -19.2% | 175,000 | 0.0% | 0.10% | -33.3% | |
RCEL | AVITA MEDICAL INC | $1,095,750 | -14.1% | 75,000 | 0.0% | 0.10% | -28.9% | |
KRTX | Sell | KARUNA THERAPEUTICS INC | $1,088,940 | -64.5% | 6,440 | -54.5% | 0.10% | -70.7% |
AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,071,200 | -78.8% | 104,000 | -66.1% | 0.10% | -82.4% |
ALPN | ALPINE IMMUNE SCIENCES INC | $1,008,436 | +11.4% | 88,073 | 0.0% | 0.09% | -7.9% | |
YMAB | Y-MABS THERAPEUTICS INC | $856,642 | -19.7% | 157,182 | 0.0% | 0.08% | -33.6% | |
New | APOGEE THERAPEUTICS INC | $745,500 | – | 35,000 | +100.0% | 0.07% | – | |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $690,690 | – | 3,900 | +100.0% | 0.06% | – |
GLTO | Sell | GALECTO INC | $645,864 | -74.4% | 897,657 | -10.2% | 0.06% | -78.6% |
DCTH | New | DELCATH SYS INC | $587,080 | – | 144,958 | +100.0% | 0.05% | – |
Sell | XERIS BIOPHARMA HOLDINGS INC | $565,594 | -89.5% | 304,083 | -85.2% | 0.05% | -91.3% | |
SBTX | New | ARS PHARMACEUTICALS INC | $567,000 | – | 150,000 | +100.0% | 0.05% | – |
XILIO THERAPEUTICS INC | $478,846 | -19.5% | 226,941 | 0.0% | 0.04% | -33.3% | ||
IMUX | IMMUNIC INC | $441,000 | -41.4% | 300,000 | 0.0% | 0.04% | -51.2% | |
KROS | Sell | KEROS THERAPEUTICS INC | $404,876 | -85.8% | 12,700 | -82.1% | 0.04% | -88.3% |
STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -25,887 | -100.0% | -0.01% | – |
Exit | PARAGON 28 INC | $0 | – | -10,000 | -100.0% | -0.02% | – | |
TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -21,600 | -100.0% | -0.04% | – |
Exit | INDIVIOR PLCord | $0 | – | -18,624 | -100.0% | -0.05% | – | |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -13,600 | -100.0% | -0.05% | – |
VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -21,700 | -100.0% | -0.05% | – |
ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -320,000 | -100.0% | -0.06% | – |
LUNG | Exit | PULMONX CORP | $0 | – | -41,000 | -100.0% | -0.06% | – |
PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -33,500 | -100.0% | -0.07% | – |
RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -38,600 | -100.0% | -0.07% | – |
Exit | VENTYX BIOSCIENCES INC | $0 | – | -21,300 | -100.0% | -0.08% | – | |
MORF | Exit | MORPHIC HLDG INC | $0 | – | -13,600 | -100.0% | -0.09% | – |
VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -34,000 | -100.0% | -0.09% | – |
IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -16,400 | -100.0% | -0.11% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -39,800 | -100.0% | -0.12% | – |
Exit | MINERALYS THERAPEUTICS INC | $0 | – | -76,817 | -100.0% | -0.15% | – | |
CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -46,000 | -100.0% | -0.16% | – |
ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -151,000 | -100.0% | -0.17% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -4,300 | -100.0% | -0.22% | – |
BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -435,000 | -100.0% | -0.24% | – |
CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -42,400 | -100.0% | -0.26% | – |
VCEL | Exit | VERICEL CORP | $0 | – | -67,049 | -100.0% | -0.28% | – |
Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -0.29% | – | |
TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -160,000 | -100.0% | -0.36% | – |
Exit | DICE THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -0.41% | – | |
CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -373,000 | -100.0% | -0.45% | – |
DXCM | Exit | DEXCOM INC | $0 | – | -33,000 | -100.0% | -0.47% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -57,800 | -100.0% | -0.56% | – |
TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -74,200 | -100.0% | -0.69% | – |
BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -364,000 | -100.0% | -0.70% | – |
THTX | Exit | THERATECHNOLOGIES INC | $0 | – | -9,325,511 | -100.0% | -0.87% | – |
ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -768,500 | -100.0% | -0.89% | – |
ILMN | Exit | ILLUMINA INC | $0 | – | -45,900 | -100.0% | -0.96% | – |
RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -97,547 | -100.0% | -1.11% | – |
SGEN | Exit | SEAGEN INC | $0 | – | -71,000 | -100.0% | -1.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
IRADIMED CORP | 16 | Q3 2023 | 5.8% |
XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
SURMODICS INC | 14 | Q3 2023 | 4.7% |
NATERA INC | 13 | Q3 2023 | 3.9% |
DEXCOM INC | 13 | Q2 2023 | 4.2% |
NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.